MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), ...
Hexavalent, six-in-one vaccine can reduce spread of the disease and cut costs ANALYSIS | ESTHER NAKKAZI | Pertussis, or ...
New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results ...
Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate for the ...
Results from this study could support an extension of the current approval of MVA-BN to include children from 2 years of age ...
MSNBC on MSN12dOpinion
Opinion | The disbelief and alarm of being a doctor watching Trump's plans to destroy public healthHoward Lutnick has suggested Robert F. Kennedy Jr., a notorious anti-vaccine activist, may be granted access to federal ...
COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...
Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...
As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback